Skip to main content

MoneyWorks4Me

Cadila Healthcare informs about press release

12 Nov 2018 Evaluate

Cadila Healthcare has informed about submission of a copy of press release dated November 12, 2018 titled ‘Zydus receives final approval from the USFDA for Nystatin and Triamcinolone Acetonide Ointment USP’. 

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1905.00
Dr. Reddys Labs. 1385.00
Cipla 1406.00
Lupin 2012.00
Zydus Lifesciences 1213.05
View more..